BIRX DEBORAH (Chief Executive Officer) reported 2 transactions at ARMATA PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/25/2025ACC: 0001104659-25-039417
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-28.99K
Net shares
Net seller
$73.3K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
28.99K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−22.93K
Price / share
$2.68
Trade value
$61.44K
% of position
8.8%
7/10/2024
260K→237.07K
Common Stock
Direct
Shares
−6.06K
Price / share
$1.95
Trade value
$11.82K
% of position
2.6%
3/14/2025
237.07K→231.01K
Total
Net shares
−28.99K
Net value
-$73.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/10/2024 | F · Tax Withholding | −22.93K | $2.68 | $61.44K | 8.8% | 260K | 237.07K |
| Common Stock Direct | 3/14/2025 | F · Tax Withholding | −6.06K | $1.95 | $11.82K | 2.6% | 237.07K | 231.01K |
| Total | −28.99K | -$73.26K | ||||||
Derivative Transactions0
No derivative transactions reported